Inventor · disambiguated record
Mathias Oelke
Also filed as: OELKE MATHIAS
5 granted patents·11 pending applications·10 citations·filing 2003–2023
73Inventor score
Top patents by PatentIndex Score
16 records- 0189US10098939B2Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cellsUNIV JOHNS HOPKINS·Filed 2017·Granted Oct 16, 2018·5 cites·20 claims
- 0284US10987412B2Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cellsUNIV JOHNS HOPKINS·Filed 2015·Granted Apr 27, 2021·3 cites·27 claims
- 0370US11007222B2T cell compositions with improved phenotypic propertiesNEXIMMUNE INC·Filed 2019·Granted May 18, 2021·1 cites·21 claims
- 0468US11939595B2Nanoscale artificial antigen presenting cellsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 26, 2024·0 cites·16 claims
- 0568US10435668B2Nanoscale artificial antigen presenting cellsUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 8, 2019·1 cites·15 claims
- 0665US2023332131A1Production of antigen-specific t-cellsNEXIMMUNE INC·Filed 2023·Application pending·0 cites
- 0764US2010008920A1Reagents and Methods for Engaging Unique Clonotypic Lymphocyte ReceptorsUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 0863US2021252121A1Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cellsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0957US2023399613A1Cell compositions comprising antigen-specific t cells for adoptive therapyNEXIMMUNE INC·Filed 2022·Application pending·0 cites
- 1056US2017261497A1Reagents and Methods for Engaging Unique Clonotypic Lymphocyte ReceptorsUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1149US2020291381A1Production of antigen-specific t-cellsNEXIMMUNE INC·Filed 2017·Application pending·0 cites
- 1248US2004115216A1Reagents and methods for engaging unique clonotypic lymphocyte receptorsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 1348US2020188435A1T cell compositions with improved phenotypic propertiesNEXLMMUNE INC·Filed 2019·Application pending·0 cites
- 1446US2019119639A1Cell compositions comprising antigen-specific t cells for adoptive therapyNEXLMMUNE INC·Filed 2018·Application pending·0 cites
- 1545US2011256147A1Diagnostic and treatment methods for cancer based on immune inhibitorsUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 1635US2011300168A1Compositions and methods for inducing an immune response against influenza antigensSCHNECK JONATHAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathias Oelke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →